Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Pfizer Inc.

Market Cap 146B 127B 117B 109B 204B 13,968B 208B 1,385B 537B 6,755B 550B 538B 23,475B P/E ratio 2026 *
12x
P/E ratio 2027 * 13x
Enterprise value 195B 168B 155B 145B 272B 18,571B 277B 1,841B 715B 8,982B 731B 715B 31,212B EV / Sales 2026 *
3.16x
EV / Sales 2027 * 3.18x
Free-Float
59.05%
Yield 2026 *
6.82%
Yield 2027 * 6.79%
1 day-0.68%
1 week+0.59%
Current month-1.83%
1 month+0.08%
3 months-4.14%
6 months+1.46%
Current year+3.21%
1 week 25.47
Extreme 25.4701
26.22
1 month 25.19
Extreme 25.19
26.54
Current year 24.83
Extreme 24.83
28.74
1 year 23.11
Extreme 23.11
28.74
3 years 20.92
Extreme 20.915
40.36
5 years 20.92
Extreme 20.915
61.71
10 years 20.92
Extreme 20.915
61.71
Manager TitleAgeSince
Chief Executive Officer 64 01/01/2019
Director of Finance/CFO 61 02/05/2022
Chief Tech/Sci/R&D Officer - 01/01/2007
Director TitleAgeSince
Director/Board Member 68 01/09/2007
Director/Board Member 62 27/09/2013
Chairman 64 01/01/2020
Date Insider Type Main position Quantity % Market Cap.
29/05Free

Chief Executive Officer

23 0.0000%
15/05Free

Chief Executive Officer

24 0.0000%
30/04Free

Chief Executive Officer

22 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%+0.59%+7.22%-34.05% 146B
-0.39%+7.57%+47.95%+156.63% 1,025B
+2.08%+6.33%+52.68%+48.12% 559B
+1.05%+4.65%+19.17%+63.14% 394B
+0.77%+5.62%+21.96%+15.95% 324B
-1.19%+3.16%+26.55%+16.39% 286B
+0.89%+4.76%+21.94%+31.29% 270B
-0.34%+4.97%+18.82%+57.51% 187B
-0.92%-2.94%-45.04%-50.62% 186B
-2.03%-1.62%+11.06%+60.65% 159B
Average -0.08%+2.72%+18.23%+36.50% 353.61B
Weighted average by Cap. +0.19%+4.45%+29.61%+66.90%

Financials

2026 *2027 *
Net sales 61.69B 53.36B 49.17B 46.08B 86.08B 5,883B 87.65B 583B 226B 2,845B 232B 227B 9,887B 59.32B 51.31B 47.28B 44.31B 82.77B 5,657B 84.28B 561B 218B 2,736B 223B 218B 9,507B
Net income 11.07B 9.58B 8.82B 8.27B 15.45B 1,056B 15.73B 105B 40.62B 511B 41.57B 40.66B 1,774B 10.72B 9.27B 8.54B 8.01B 14.95B 1,022B 15.23B 101B 39.32B 494B 40.24B 39.37B 1,718B
Net Debt 48.28B 41.76B 38.48B 36.06B 67.36B 4,604B 68.59B 456B 177B 2,226B 181B 177B 7,737B 42.08B 36.4B 33.54B 31.43B 58.71B 4,012B 59.78B 398B 154B 1,941B 158B 155B 6,743B
Logo Pfizer Inc.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.
Employees
75,000
Date Price Change Volume
09/06/26 25.70 $ +0.31% 35,245,781
08/06/26 25.62 $ -1.61% 42,028,801
05/06/26 26.04 $ +1.36% 32,218,530
04/06/26 25.69 $ +1.38% 31,272,004
03/06/26 25.34 $ -0.82% 30,957,066
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
25.70USD
Average target price
29.19USD
Spread / Average Target
+13.57%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW